ArticlePharmacology research & perspectives2021

CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.

Amlan Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.